These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 19758653)

  • 1. Editorial comment.
    Gardiner RA
    J Urol; 2009 Nov; 182(5):2121; discussion 2122. PubMed ID: 19758653
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment.
    Chen DY
    J Urol; 2009 Nov; 182(5):2120-1; discussion 2122. PubMed ID: 19758612
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial comment.
    Roobol MJ
    J Urol; 2010 Mar; 183(3):950; discussion 950-1. PubMed ID: 20083282
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment.
    Garzotto M
    J Urol; 2010 Aug; 184(2):500. PubMed ID: 20620407
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial comment.
    Murtola T
    J Urol; 2010 Aug; 184(2):500. PubMed ID: 20620406
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial comment.
    Magheli A; Gonzalgo ML
    J Urol; 2009 Nov; 182(5):2248; discussion 2248-9. PubMed ID: 19758637
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial comment on: preliminary results of a novel method to estimate the probability of prostate cancer in men with elevated serum PSA values.
    Chun FK; Briganti A
    Eur Urol; 2008 Sep; 54(3):702. PubMed ID: 18403097
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment on: Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).
    Terris MK
    Eur Urol; 2009 Feb; 55(2):392; discussion 393. PubMed ID: 18353530
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial comment on: diagnostic value of free prostate-specific antigen among men with a prostate-specific antigen level of <3.0 microg per liter.
    Stephan C; Jung K
    Eur Urol; 2008 Aug; 54(2):369-70. PubMed ID: 18006212
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial comment on: diagnostic value of free prostate-specific antigen among men with a prostate-specific antigen level of <3.0 microg per liter.
    Froehner M
    Eur Urol; 2008 Aug; 54(2):368-9. PubMed ID: 18006213
    [No Abstract]   [Full Text] [Related]  

  • 11. A framework for the identification of men at increased risk for prostate cancer.
    Roobol MJ; Schröder FH; Crawford ED; Freedland SJ; Sartor AO; Fleshner N; Andriole GL
    J Urol; 2009 Nov; 182(5):2112-20. PubMed ID: 19758625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualized assessment of prostate cancer risk.
    Adolfsson J
    Nat Clin Pract Urol; 2006 Oct; 3(10):522-3. PubMed ID: 17031373
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial comment.
    Carter HB
    Urology; 2009 Jul; 74(1):183; aurhor reply 183-4. PubMed ID: 19567300
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening for prostate cancer.
    Brawley OW; Ankerst DP; Thompson IM
    CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial comment.
    Krieger JN
    J Urol; 2010 Mar; 183(3):944-5; discussion 945. PubMed ID: 20089278
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial comment.
    Baltaci S
    J Urol; 2010 Mar; 183(3):944; discussion 945. PubMed ID: 20089266
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial comment on: Insignificant prostate cancer and active surveillance: from definition to clinical implications.
    Albertson PC
    Eur Urol; 2009 Jun; 55(6):1331-2. PubMed ID: 19286304
    [No Abstract]   [Full Text] [Related]  

  • 18. Precursor isoform of prostate-specific antigen and human kallikrein 2: two new promising biomarkers for the unsolved challenge of early prostate cancer detection.
    Ficarra V; Novara G; Galfano A
    Eur Urol; 2009 Mar; 55(3):556-9. PubMed ID: 19111385
    [No Abstract]   [Full Text] [Related]  

  • 19. Upcoming evidences on prostate-specific antigen-based screening for men at risk of prostate cancer.
    Boscolo-Berto R
    Int J Urol; 2009 Sep; 16(9):711. PubMed ID: 19769655
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial comment on: reassessing the diagnostic yield of saturation biopsy of the prostate.
    Philip J
    Eur Urol; 2008 May; 53(5):981-2. PubMed ID: 17997013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.